Recently, targeting both EGFR overexpression and Integrin B1 signaling was shown to radiosensitize HNSCC cells, building on previous literature demonstrating Integrin aberrations in HNSCC [9]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.